Related by context. All words. (Click for frequent words.) 70 etiologic agent 70 serologic testing 69 serological tests 67 enterococcal 67 K ras mutations 67 T SPOT.TB 67 S. maltophilia 67 enteroviral 66 humoral responses 66 coinfection 66 bronchoalveolar lavage 66 fluoroquinolone resistance 66 murine models 66 quasispecies 66 Gram stain 66 serologically 66 immunohistochemical analysis 66 epithelial tumors 65 transfusion transmitted 65 clinicopathologic 65 Serologic 65 immunological responses 65 intestinal biopsy 65 ELISPOT 65 sonographic diagnosis 65 Infectivity 65 serologic 64 Opportunistic infections 64 genotypic resistance 64 gastric adenocarcinoma 64 ANCA associated 64 sCJD 64 immunocompetent 64 gene rearrangements 64 S. suis 64 gonococcal 64 replicase 64 clade B 64 N. gonorrhoeae 64 diagnostic biomarker 64 fluconazole resistant 64 chest radiographs 64 immunohistochemical 64 herpesviruses 64 KRAS mutation 64 PCR assay 64 RQ PCR 64 virulence genes 64 Candida infection 64 Lymph node 64 viral isolates 64 S OIV 64 gastric carcinoma 64 etiologic 64 Trichomonas vaginalis 64 percutaneous biopsy 63 bronchoalveolar 63 IgM antibody 63 microsatellite instability 63 metastatic lymph nodes 63 polymicrobial 63 M. pneumoniae 63 Histologically 63 microbiologic 63 etiologic factors 63 antibiotic susceptibility 63 candidemia 63 replicon 63 modifier genes 63 Anaplasma 63 imatinib resistance 63 IGRAs 63 obstructive coronary artery 63 recurrent glioblastoma multiforme 63 antiphospholipid antibodies 63 endometrial biopsy 63 molecular diagnostic assay 63 seronegative 63 precursor lesions 63 #S rRNA gene 63 hepatitis viruses 63 vancomycin resistant 63 #q# deletion 63 metaplasia 63 demyelinating 63 ELISpot 63 P aeruginosa 63 P. falciparum malaria 63 Tr DNA 63 Bacteremia 63 induced sputum 63 prognostically 63 chlamydial 63 combination antiretroviral therapy 63 genital ulcer 63 urine cytology 63 metastatic neuroendocrine tumors 63 HER2 expression 63 EBV infection 63 sputum specimens 63 gonococcal infection 62 IgA deficiency 62 Trichophyton rubrum 62 stool specimen 62 susceptibility loci 62 thyroid carcinoma 62 extramedullary 62 angiographically 62 methylation markers 62 monogenic 62 prognostic indicators 62 molecular biomarkers 62 sporadic Creutzfeldt Jakob 62 tumorigenicity 62 nodal metastasis 62 lymphocytic 62 bone scintigraphy 62 S. neurona 62 H pylori 62 syndromic 62 fluoroquinolone resistant 62 paratuberculosis 62 aetiological 62 pulmonary metastases 62 haematologic 62 hepatoma 62 Variant Creutzfeldt Jakob Disease 62 arteritis 62 C. trachomatis 62 esophageal gastric 62 skeletal metastases 62 lupus scleroderma 62 prognostic markers 62 E. faecalis 62 malignant lymphomas 62 NRTI resistance 62 Squamous 62 Genetic variants 62 latent tuberculosis TB 62 coinfected patients 62 BRAF V#E mutation 62 Chlamydia pneumoniae 62 sonographic appearance 62 missense mutations 62 intracellular bacteria 62 clinicopathological 62 Neisseria gonorrhoeae 62 C. difficile toxins 62 enzyme immunoassay EIA 62 quinolone resistant 62 transgenic rats 62 Salmonella spp 62 Histologic 62 normal karyotype 62 L. pneumophila 62 sero positive 62 molecular determinants 62 methicillin susceptible Staphylococcus aureus 62 genomic alterations 62 orchitis 62 biomarker identification 61 bullous 61 vivax 61 diagnosing coronary artery 61 pentoxifylline 61 granulomatous 61 HER2 overexpression 61 phenotypic expression 61 Francisella 61 haematological 61 genetic loci 61 immune dysregulation 61 Hurthle cell 61 scintigraphic 61 AST ALT 61 hepatocellular carcinomas 61 preoperative diagnosis 61 resected tumors 61 histologically proven 61 hemorrhagic cystitis 61 ALK mutations 61 Thiovir 61 G6PD deficiency 61 mesenteric 61 intra abdominal infections 61 leiomyomas 61 pilocytic astrocytomas 61 chlamydial infection 61 acute respiratory tract infections 61 immunofluorescent 61 Coxiella burnetii 61 seropositivity 61 cervical lymph node 61 Babesia 61 antiphospholipid syndrome 61 HLA DQ2 61 IgG4 61 Salmonella Campylobacter 61 neuroendocrine cancers 61 Candida species 61 postexposure prophylaxis 61 polycythemia vera PV 61 FDG PET imaging 61 coagulase negative staphylococci 61 genital secretions 61 subtyped 61 biomarker assay 61 obstructive coronary 61 Trypanosoma 61 CHIKV 61 serological testing 61 radiographic findings 61 noninfectious 61 pretransplant 61 VP# [004] 61 HBeAg negative 61 Enterococcus faecium 61 lymphoid tumors 61 Chlamydia trachomatis infection 61 diagnose coronary artery 61 etiological agent 61 hemoglobinopathies 61 latent celiac disease 61 parasitemia 61 viral etiology 61 IDH mutations 61 Alequel 61 bronchial epithelial cells 61 benign moles 61 histologic findings 61 Borrelia 61 papillary renal cell carcinoma 61 cholera toxin 61 H. influenzae 61 colorectal adenocarcinoma 61 Pneumocystis carinii pneumonia 61 obligate intracellular 61 isotypes 61 familial clustering 61 haematopoietic 61 p# biomarker 61 histopathologic diagnosis 61 neoplasias 61 fungal colonization 61 recombinants 61 Pseudomonas aeruginosa infections 61 therapeutic regimens 61 BCR ABL mutations 61 Balamuthia 61 gingivalis 61 gene amplification 61 hypervirulent 61 tuberculin skin test 61 PCA3 gene 61 Epstein Barr virus EBV 61 ESBL producing E. coli 61 EGFR mutation status 61 tumor subtypes 61 outer membrane proteins 61 hyperacute 61 aberrant immune 61 S aureus 61 histological subtypes 61 trastuzumab Herceptin ® 61 carcinomatosis 61 histologic diagnosis 61 causative organism 61 somatic mutations 61 trichomonas 61 DNA methylation patterns 61 NNRTI resistant virus 61 neuroendocrine carcinoma 61 cytologic 61 A. phagocytophilum 61 putative biomarkers 61 histological subtype 60 chemokine receptors 60 pathologic examination 60 mammographically 60 Leukemias 60 Corynebacterium 60 enteric pathogens 60 chromosomal aberrations 60 immunoblot 60 stratifying patients 60 bovine thrombin 60 murine model 60 immunochemical 60 MMP inhibitors 60 prophylactic cranial irradiation 60 GIST tumors 60 comorbid depression 60 immunopathology 60 hypercoagulable 60 Staphylococcus epidermidis 60 pituitary adenomas 60 febrile illnesses 60 B. burgdorferi 60 virologic responses 60 GABHS 60 serum antibodies 60 rickettsial 60 histopathologic examination 60 lichen planus 60 genomic biomarker 60 sarcomatoid 60 antibody titer 60 diagnostic modality 60 Leydig cell 60 epithelial barrier 60 molecular subtypes 60 thrombophilia 60 methicillin sensitive 60 ELISA assays 60 NSCLC tumors 60 tuberculin skin testing 60 IgM antibodies 60 chemoprevention trials 60 liver metastasis 60 biologic pathways 60 nasal carriage 60 ESBLs 60 dual tropic 60 serous ovarian cancer 60 viral nucleic acids 60 nonalcoholic steatohepatitis NASH 60 thymidine kinase 60 KRAS oncogene 60 pathogenic mechanisms 60 idiopathic myelofibrosis 60 murine leukemia virus 60 #S rDNA 60 percutaneous drainage 60 refractory Hodgkin 60 prognostic biomarkers 60 squamous cell lung cancer 60 sinonasal 60 vascularisation 60 Chronic lymphocytic leukemia 60 predisposing factors 60 linezolid resistant 60 capsular polysaccharide 60 Mantoux test 60 coagulation abnormalities 60 coagulation disorders 60 HER2 positive cancers 60 innate immune responses 60 #F FDG PET 60 SSc 60 causative organisms 60 paraneoplastic 60 Enterobacter cloacae 60 histological diagnosis 60 tumoral 60 proctitis 60 dermatophytes 60 MGUS 60 myeloproliferative diseases 60 surrogate markers 60 p# antigen 60 cellular immunotherapy 60 microRNA biomarkers 60 Immunohistochemical 60 Epstein Barr Virus EBV 60 TMPRSS2 ERG 60 multivariate analyzes 60 immunochemical fecal occult 60 Immunohistochemical staining 60 Vesivirus 60 needle aspiration 60 detecting colorectal cancer 60 nonhuman primate model 60 calculi 60 cervical lymph nodes 60 etiologies 60 gastrointestinal stromal tumors GISTs 60 Bordetella pertussis 60 bronchogenic carcinoma 60 prognostic biomarker 60 Histological 60 mycosis fungoides 60 Chlamydia gonorrhea 60 Mantoux 60 nontuberculous mycobacteria 60 HCV antibody 60 adverse cytogenetics 60 TMPRSS2 ERG fusion 60 HER2/neu 60 myelofibrosis polycythemia vera 60 neutralizing antibody responses 60 adeno associated viruses 60 empiric therapy 60 renal biopsy 60 latent tuberculosis infection 60 HPV subtypes 60 transgene expression 60 gastric carcinomas 60 ALI ARDS 60 Gag polymorphisms 60 viral hemorrhagic fevers 60 hepatic liver 60 allogeneic HSCT 60 Lymphoid 60 APOE genotype 60 proliferative disorders 60 causative agents 60 urothelial carcinoma 60 Haptoglobin 60 causative mutations 60 virus HBV 60 transient elastography 60 renal cysts 60 P vivax 60 LVNC 60 pancreatic ductal 60 T. vaginalis 60 genetic polymorphisms 60 prognostic indicator 60 carcinoids 60 NNRTI resistance 60 xTAG RVP 60 hematological parameters 60 aminotransferase 60 obscure gastrointestinal bleeding 60 intestinal metaplasia 60 Chlamydia trachomatis 60 sarcoid 60 bacterium Neisseria meningitidis 60 attenuated strain 60 T SPOT.TB test 60 radioimmunotherapy RIT 60 bacterial parasitic 60 HIV coinfected 60 e antigen HBeAg 60 anal HPV 60 flavopiridol 60 extrapulmonary 60 Serological 60 mitochondrial toxicity 60 breast endometrial 60 GBA mutations 60 R5 tropic 60 aerodigestive tract 60 mucinous 60 colonic polyps 60 thrombotic thrombocytopenic purpura TTP 59 serogroup B 59 cranial irradiation 59 amebiasis 59 teratogens 59 NAbs 59 multidrug 59 circulating endothelial cells 59 surgically resectable 59 N glycan 59 R. equi 59 serological 59 bacteraemia 59 urothelial cancer 59 tumor subtype 59 mediastinitis 59 bronchoalveolar lavage BAL 59 histologic subtypes 59 PFGE 59 osteosarcomas 59 S. Typhimurium 59 Genetic susceptibility 59 prion infection 59 familial polyposis 59 anti androgens 59 Neisseria meningitides 59 Enterobacter 59 nonbacterial 59 prognostic marker 59 mycobacterial 59 pylori 59 ovarian malignancy 59 vasogenic edema 59 potent inducer 59 bloodborne 59 Prognostic factors 59 serotype #A 59 breast cancer subtypes 59 histologic examination 59 MYH9 gene 59 SLNB 59 endocrine therapies 59 SIADH 59 virally induced 59 nasopharyngeal swabs 59 subtilis 59 tumor histology 59 Lyme arthritis 59 pleural fluid 59 FGFs 59 immunodeficiency disorders 59 Venous thromboembolism 59 KRAS BRAF 59 LCMV infection 59 aneuploidies 59 cervicitis 59 assay detects 59 neurosensory 59 hepatic enzymes 59 B. cepacia 59 CP CPPS 59 sonographic evaluation 59 abnormal cytology 59 enterocolitis 59 radiolabeled TM# 59 fibrosarcoma 59 Escherichia coli O# 59 p# activation 59 Plasmodium vivax 59 eTag assays 59 fibroma 59 perfusion MRI 59 recurrent bladder 59 gonorrhoeae 59 PARP inhibition 59 histologic subtype 59 lymphoproliferative disorders 59 neurocognitive impairment 59 P. gingivalis 59 Fibroblast 59 chromosomal mutations 59 RT qPCR 59 idiopathic PAH 59 HCV Hepatitis C 59 pharmacodynamic biomarkers 59 P. malariae 59 extrapulmonary disease 59 DNA methylation biomarkers 59 intestinal mucosa 59 HER2 amplification 59 histopathological 59 neuropsychological impairments 59 liposomal amphotericin B 59 Cytogenetic 59 multivalent vaccine 59 gastric mucosa 59 multivessel coronary artery 59 biologic pathway 59 asymptomatic carriers 59 cystic fibrosis chronic pancreatitis 59 ultrastructural 59 humoral immune response 59 antifungal medications 59 smear microscopy 59 Aeromonas 59 Mutation Analysis 59 acid suppressive drugs 59 Entamoeba histolytica 59 Cryptococcus neoformans 59 pathologic diagnosis 59 benign neoplasms 59 KRAS status 59 aT cell 59 Typhimurium 59 differential diagnoses 59 hamartomas 59 subtyping 59 pT2 59 immunomodulation 59 Histopathologic 59 myopathies 59 immunosuppressant therapy 59 microscopic colitis 59 serum antibody 59 antigenicity 59 molecular biomarker 59 transcriptomic 59 Multidrug resistant 59 sequence homology 59 multivariate regression analysis 59 multidrug resistant MDR 59 immunodeficient 59 interferon γ 59 germline mutations 59 renal scarring 59 CellSearch ™ 59 Interferon Beta 59 C. jejuni 59 antiangiogenic agent 59 neuroblastoma tumors 59 NEUGENE 59 mechanistic insights 59 antiretroviral naïve 59 inflammatory bowel syndrome 59 HIV1 59 hyperinsulinism 59 antinuclear antibodies 59 Prenatal diagnosis 59 chromosomal rearrangement 59 PBMCs 59 haematuria 59 Immunohistochemical analysis 59 primary hyperparathyroidism 59 infectious prion proteins 59 busulfan 59 chromosomal anomalies 59 RDTs 59 C. pneumoniae 59 co receptor tropism 59 ABCB1 59 operons 59 HbF 59 Immune responses 59 papillomavirus 59 endoscopic ultrasonography 59 pre malignant lesions 59 BEXXAR Therapeutic Regimen 59 malayi 59 ASCUS 59 causative mutation 59 eosinophilic 59 multiplex assay 59 coagulase negative 59 oncogenic mutations 59 node metastasis 59 T1c 59 Plasmodium parasites 59 IgG1 antibodies 59 cytologically 59 colonoscopy sigmoidoscopy 59 parenteral antibiotics 59 FluCAM arm 59 Genotypes 59 microdeletion 59 coinfections 59 antibody mediated 59 Amgen Neulasta ® 59 metastatic melanomas 59 low expressors 59 rhinovirus infections 59 Ribavirin causes 59 Rimantadine 59 Nonalcoholic fatty liver 59 familial aggregation 59 biochemical abnormalities 59 breast carcinoma 59 miRview squamous 59 dermatophyte 59 prostate abnormalities 59 Autoimmune hepatitis 59 IgG antibodies 59 Catheter Associated 59 enteroviral infection 59 nonpathogenic 58 Campylobacter spp 58 HBV genotype 58 H5 viruses 58 cytomegalovirus infection 58 PCNSL 58 HLA DRB1 58 renal carcinoma 58 immunosuppressed patients 58 WNV infections 58 BCL#A 58 hereditary predisposition 58 transrectal ultrasound guided 58 HNSCC 58 tryptase 58 neoplastic 58 antibiotic regimens 58 nosocomial transmission 58 sarcoids 58 virus XMRV 58 methicillin resistant S. aureus 58 vaginal lesions 58 Cytomegalovirus CMV 58 p#INK#a 58 hepatic fibrosis 58 ano genital warts 58 HIV seropositive 58 protein antigens 58 histopathological examination 58 type II pneumocytes 58 CIN2 + 58 causative pathogen 58 genital ulcers 58 pyelonephritis 58 Histoplasmosis 58 TPMT 58 antitumor efficacy 58 ADAMTS# 58 prostate cancer CaP 58 VNTR 58 underlying pathophysiology 58 erythema nodosum 58 ALK inhibitors 58 Mycobacterium bovis 58 varicella infection 58 superinfection 58 lymphoid organs 58 Genetic predisposition 58 causal variants 58 griseofulvin 58 NMIBC 58 kinase inhibition 58 NNRTI resistant 58 clonal expansion 58 clinicopathological features 58 hyperplastic polyps 58 recurrent metastatic 58 sonographic findings 58 splenic 58 hemolytic 58 kallikrein 58 arteriography 58 invasive lobular 58 Salmonella enterica 58 invasive candidiasis 58 nonvaccine 58 Chemokine Receptor 58 neuro developmental disorders 58 gynaecologic 58 mycosis 58 prostate carcinoma 58 atopic asthma 58 predictive biomarkers 58 pelvic ultrasound 58 Varicella zoster virus 58 B. longum 58 mitochondrial metabolism 58 renal tubular 58 renal cell carcinomas 58 distinct subtypes 58 Herpes Simplex 58 HIV serostatus 58 Human papillomavirus 58 tick borne infections 58 lymphoid cells 58 de novo mutations 58 adenomatous 58 Cepheid Xpert 58 dengue serotype 58 demyelinating disease 58 Amplicor 58 HIVAN 58 NPM1 58 adrenocortical cancer 58 BALB c mice 58 serovar 58 metabolomic profiles 58 polycythemia vera essential thrombocythemia 58 genes differentially expressed 58 Lipodystrophy 58 HLA DRB1 * 58 gp# protein [002] 58 subclinical disease 58 CYP #D# 58 decompensated cirrhosis 58 anti JCV antibodies 58 N. meningitidis 58 COL#A# 58 miRview ™ squamous 58 meticillin resistant Staphylococcus aureus 58 anti angiogenic agents 58 Fanconi syndrome 58 Anaplasmosis 58 Mycobacterium leprae 58 cSSSIs 58 Amgen Neulasta R 58 cryptococcal meningitis 58 RT PCR assay 58 carcinoid 58 reaction PCR 58 staphylococci 58 oncological outcomes 58 allogeneic transplant 58 rotaviruses 58 psoriasis Crohn disease 58 thiopurine 58 neurologic symptoms 58 antimicrobial susceptibility testing 58 Leptospira 58 Bartonella species 58 Herpes simplex virus 58 hormone receptor negative 58 paragangliomas 58 meningitis encephalitis 58 HRCT 58 tTG 58 genomic biomarkers 58 IgG2 58 paramyxoviruses 58 Salmonella typhi 58 predisposing factor 58 completely resected 58 immune modulating 58 System IPSS 58 deep sternal wound 58 molecular abnormalities 58 oesophageal adenocarcinoma 58 gonococcal infections 58 BRAF V# mutation 58 differential gene expression 58 sputum sample 58 Lymphocytic 58 malignant phenotype 58 human leukocyte antigens 58 S. enterica 58 DNA methylation markers 58 F FDG PET 58 lymph node enlargement 58 affective psychosis 58 nonalcoholic steatohepatitis 58 empiric treatment 58 Meta analyzes 58 PIK3CA 58 neurotrophic 58 molecular assays 58 colorectal carcinogenesis 58 squamous 58 chlamydial infections 58 kidney urologic 58 endometrial hyperplasia 58 florbetaben 58 germline mutation 58 Staphylococcus bacteria 58 RAS mutations 58 transgenic mouse models 58 induced anemia 58 M. catarrhalis 58 osteoid 58 ImmuKnow 58 genetic determinants 58 Gleevec resistant 58 Entamoeba 58 splice variants 58 systemic amyloidosis 58 serum biomarkers 58 thrombo embolic 58 UGT#A# 58 haemolytic 58 encephalomyelitis 58 proviral 58 vesicoureteral reflux VUR 58 eradicate H. pylori 58 KRAS mutations 58 lenalidomide dexamethasone 58 riociguat 58 pancreatic lung 58 dorsal root ganglion 58 cisplatin resistant 58 Plasmodium ovale 58 adjuvant therapies 58 simplex virus 58 mechanistic studies 58 lipodystrophy syndrome 58 HIV HCV coinfected 58 retrovirus XMRV 58 gene loci 58 collagen vascular 58 hematopoietic cancers 58 immunofluorescence staining 58 mycotic 58 invasive lobular carcinoma 58 premalignant lesions 58 supratentorial 58 pharmacologic intervention 58 Probiotic bacteria 58 hepatic arterial 58 unresectable tumors 58 multi analyte 58 humoral immunity 58 HBV vaccine 58 enteric viruses 58 Pelvic inflammatory 58 genetic aberrations 58 neutralizing antibody 58 infecting organism 58 proteomic analysis 58 genital ulcer disease 58 NS4A 58 Clostridia 58 osteoblastic 58 Sjögren syndrome 58 prostate carcinomas 58 proteomic analyzes 58 viral titers 58 vimentin 58 neuropsychiatric diseases 58 pharmacodynamic PD 58 antimicrobial susceptibility 58 viral nucleic acid 58 definitively diagnose 58 pathophysiological mechanisms 58 virological response 58 genomewide 58 PROCHYMAL 58 TGFBR1 * 6A 58 cardiac troponin 58 hemorrhagic colitis 58 malignant ascites 58 hyperplastic 58 P. ovale 58 C1q 58 severely immunosuppressed 58 differentially expressed genes 58 neovascular diseases 58 MRSA colonization 58 invasive ductal breast cancer 58 M. leprae 58 colorectal liver metastases 58 reaction RT PCR 58 Raynaud syndrome 58 hematologic malignancy 58 multidrug resistant pathogens 58 cervical neoplasia 58 Enterobacteriaceae 58 diabetic kidney 58 demyelinating diseases 58 prognostic variables 58 methylation patterns 58 Relapsing remitting MS 58 Trichinella 58 subunit vaccine 58 Asymptomatic 58 K ras 58 flavivirus 58 ERK signaling 58 enteropathy 58 parasitaemia 58 pulmonary metastasis 58 BRAF mutation 58 B7 H3 58 Apobec3 58 hyper IgE syndrome 58 urogenital infections 58 HBsAg 58 oral squamous cell 58 antiangiogenic therapy 58 abacavir Ziagen 58 glial tumors 58 cholestasis 58 Adverse effects 58 aetiology 58 locoregional recurrence 57 arterial calcification 57 abnormal vaginal bleeding 57 Progressive Multifocal Leukoencephalopathy 57 extracolonic 57 opportunistic pathogens 57 anti CD# antibodies 57 Beta thalassemia 57 vivo potency 57 tissue transglutaminase 57 lymph node biopsies 57 neuropathologic 57 plasma pharmacokinetics 57 Medullary thyroid cancer 57 intestinal permeability 57 Adenomas 57 pharmacodynamic parameters 57 tubercle bacillus 57 HLA alleles 57 neurologic complications 57 Resistant strains 57 thyroglobulin 57 K ras gene 57 colorectal neoplasms 57 bronchopulmonary dysplasia BPD 57 autoimmune thyroid 57 microdeletions 57 HER-2/neu protein 57 Genotypic 57 Clusterin 57 DermaVir Patch 57 BSE prions 57 elevated LDH 57 causative genes 57 carotid plaques 57 etiological 57 urine dipstick 57 IgE antibody 57 intravenous bisphosphonates 57 Cardiotoxicity 57 Her2/neu 57 transplantation HCT 57 intracranial hemorrhage ICH 57 Mycobacterium smegmatis 57 histologies 57 Colon polyps 57 nanoviricides ® 57 hypervirulent strain 57 Chest x rays 57 estrogen receptor ER 57 peptide antigens 57 multiple sclerosis psoriasis 57 PB1 F2 57 bacterial colonization 57 opportunistic pathogen 57 bacteria Escherichia coli 57 airway hyperresponsiveness 57 mtDNA mutations 57 immunohistochemistry IHC 57 CYT# potent vascular disrupting